Looking at Individual Equities for Spread Betting and Contracts for Differences

152406 Resource 133529 120646 120646 1165859283143 1165859283143 Controlled American Individual Equities

Spread bets and CFDs on American stocks

The following information from Bloomberg may <a href="http://www.bloomberg.com/apps/news?pid=20601084&sid=a4i7jEARwOl0&refer=stocks" target="_blank" title="contracts for differences, spread betting, spread bets, CFDs, American stocks, individual equities, American individual equities">help you make contracts for differences and spread betting decisions</a> for the day and week ahead: <div style="margin-left: 40px;"> @Road Inc. (ARDI US) rose 52 cents, or 7.7 percent, to $7.23 and traded as high as $7.24. Trimble Navigation Ltd. (TRMB US), a maker of global-positioning equipment, said in a statement that it agreed to buy @Road Inc. for $496 million, to move into the field of mobile resources management, or tracking employees in the field. Trimble will pay $7.50 a share, of which $5 will be cash and $2.50 will be a combination of cash and stock, Trimble said in a statement. Biomet Inc. (BMET US) rose $1.60, or 4 percent, to $41.50 and traded a high as $41.89. Smith & Nephew Plc, a London-based maker of medical devices, may bid more than 5 billion pounds ($9.8 billion) for the U.S. maker of artificial joints, the Sunday Telegraph reported yesterday, without saying where it got the information. A Smith & Nephew spokesman declined to comment. Claire's Stores Inc. (CLE US) rose $1.29, or 3.9 percent, to $34.29 and traded as high as $37.49. The teen-oriented jewelry retailer entered a second round of bidding and four companies made offers that were reported to be about $39 a share, Women's Wear Daily said. The deal could be valued at about $3.8 billion, or $39.50 a share, the publication said, citing unidentified people in the financial business. Corus Group Plc (CGA US) American depositary receipts, each representing two shares, gained $1.27, or 6.6 percent, to $20.64 and traded as high as $20.64. Cia. Siderurgica Nacional of Brazil raised its offer for Corus Group Plc, the U.K.'s largest steelmaker, to 4.9 billion pounds ($9.6 billion), topping a sweetened bid from Tata Steel Ltd. CSN agreed to pay 515 pence for each share, 3 percent more than the 500 pence that Mumbai- based Tata offered. Corus is recommending the CSN bid, it said in a statement. EFJ Inc. (EFJI US) rose 67 cents, or 12 percent, to $6.14 and traded as high as $6.25. The maker of radios and repeaters said in a statement that its EFJohnson Co. unit won a $76 million order from the U.S. Department of defense for portable radios and other equipment. First Niagara Financial Group Inc. (FNFG US) rose 55 cents, or 3.8 percent, to $14.91 and traded as high as $15. The holding company for First Niagara Bank, Cortland Savings Bank, and Cayuga Bank said Chief Executive Officer Paul Kolkmeyer resigned and is being replaced by Chief Financial Officer John Koelmel because Kolkmeyer and the board had a different philosophy on strategy. Global Sources Ltd. (GSOL US) gained $2.56, or 18 percent, to $16.56 and traded as high as $16.78. The company, which matches buyers and sellers through Web sites and publications, was recommended by CNBC host Jim Cramer on his ``Mad Money'' television program because it's positioned to profit from growing Chinese exports. Hubbell Inc. (HUB/B US) fell $6.54, or 12 percent, to $46.17 and traded as low as $45.63. The maker of lighting and electrical products lowered its annual profit forecast to as much as $2.58 a share, blaming a slowdown in construction work. The rating was cut to ``hold'' from ``buy'' at A.G. Edwards. Idera Pharmaceuticals Inc. (IDP US) rose 69 cents, or 12 percent, to $6.30 and traded as high as $6.99. Merck & Co. (MRK US), the second-biggest U.S. drugmaker by market value, will pay Idera as much as $445 million for compounds to enhance vaccines, including one being developed against Alzheimer's disease. Medicines Co. (MDCO US) fell $2.23, or 6.7 percent, to $30.87 and traded as low as $28.86. The U.S. Senate failed to approve a measure to extend the patent on the drug developer's only drug, the blood-thinner Angiomax. It missed by one day a deadline for seeking an extension of the Angiomax patent, which expires in 2010. Neopharm Inc. (NEOL US) fell $4.93, or 73 percent, to $1.79 and traded as low as $1.70. The biotechnology company said in a statement that its candidate for the treatment of recurrent glioblastoma multiforme did not meet the efficacy endpoint in a Phase 3 clinical trial. </div> 9 application/xml false American individual equities American stocks CFDs contracts for differences individual equities spread bets spread betting Looking at Individual Equities for Spread Betting and Contracts for Differences Spread bets and CFDs on individual equities http://www.gftuk.com/land/index.asp?aid=53 Mozilla/5.0 (Macintosh; U; PPC Mac OS X Mach-O; en-US; rv:1.8.0.8) Gecko/20061025 Firefox/1.5.0.8 127.0.0.1 127.0.0.1 mmarquit false true false false true 133529 blog blogsite/GFTUK/web